Compound 10 structure
|
Common Name | Compound 10 | ||
---|---|---|---|---|
CAS Number | 123021-85-2 | Molecular Weight | 279.26900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C12H9NO5S | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Compound 10GPR35 agonist 3 is a synthetic GPR35 agonist with an EC50value of 1.4 μM. GPR35 agonist 3 can be used for the research of various diseases, such as gastric cancer, type 2 diabetes, cardiovascular diseases, immune system and peripheral nervous system[1]. |
Name | 2-[4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]acetic acid |
---|---|
Synonym | More Synonyms |
Description | GPR35 agonist 3 is a synthetic GPR35 agonist with an EC50value of 1.4 μM. GPR35 agonist 3 can be used for the research of various diseases, such as gastric cancer, type 2 diabetes, cardiovascular diseases, immune system and peripheral nervous system[1]. |
---|---|
Related Catalog | |
Target |
EC50: 1.4 μM (GPR35)[1]. Ki: 0.0508 μM (GPR35)[1]. IC50: 0.349 μM (GPR35)[1]. |
In Vitro | GPR35 agonist 3 shows GPR35 agonist potency with an EC50 value of 1.4 μM[1]. GPR35 agonist 3 has affinity and potency for GPR35 with values of 0.0508μM (Ki) and 0.349 μM (IC50)[1]. |
Molecular Formula | C12H9NO5S |
---|---|
Molecular Weight | 279.26900 |
Exact Mass | 279.02000 |
PSA | 121.49000 |
LogP | 1.74980 |
Storage condition | 2-8°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H319 |
Precautionary Statements | P305 + P351 + P338 |
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
2-[4-[(2,4-Dioxo-5-thiazolidinylidene)methyl]phenoxy]-acetic acid |
2-(4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)acetic acid |
GPR35 Agonist,Compound 10 |